Patrick White, president of MedAxiom, explains how his organization, a network of US cardiology programs, develops solutions to address transitions of care issues. Mr White explains how the trend toward more integrated, incentivized care is changing today’s healthcare systems.
Mr White states that over a span of 10 years, 70% of MedAxiom’s 325 programs have transitioned from single-specialty cardiovascular programs to integrated programs that are now owned or leased by hospitals or health systems.
For this reason, there is an increased focus on incentivizing physicians to work together and improve quality and efficiency within the facilities that treat cardiology patients.
Mr White explains that physicians are also becoming involved by participating in bundled payment programs with the goal of improving patients’ transitions between healthcare settings. He concludes that physicians will need to lead efforts to design more efficient healthcare delivery models.
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Lp(a) and Getting a Head Start Against Heart Disease: Jeremy Wigginton, MD
April 8th 2025Lipoprotein a (Lp[a]) is a valuable tool for assessing a patient's risk of cardiovascular disease, which can facilitate earlier intervention efforts and reduce health care costs, argued Jeremy Wigginton, MD.
Read More